Search

Your search keyword '"Izzo CM"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Izzo CM" Remove constraint Author: "Izzo CM"
49 results on '"Izzo CM"'

Search Results

1. Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

2. Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy

3. Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

4. Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy

5. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

6. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI

7. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study

8. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

9. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

10. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

11. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects

12. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

13. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis

14. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina

15. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

16. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

17. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis

18. Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study

19. Treatment of HBsAg-Positive chronic active hepatitis with corticosteroids and/or azathioprine

20. Interferon in the treatment of viral chronic hepatitis

21. Evolution of HVR-1 Quasispecies after 1-Year Treatment in HIV/HCV-Coinfected Patients According to the Pattern of Response to Highly Active Antiretroviral Therapy

22. Response to Haart and Gb Virus Type C Coinfection in a Cohort of Antiretroviral-Naive HIV-Infected Individuals

23. Complications following percutaneous liver biopsy

24. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe

26. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

27. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection

28. Investigation of intestine function during acute viral hepatitis using combined sugar oral loads

29. [Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies]

30. Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice.

31. [Use of PCR for TB bacteria on BAL in early diagnosis of tubercular lobitis].

32. [Sexual exposure to HIV, sexual behaviour and use of pharmacological post-exposure prophylaxis (PEP)].

33. Clinical case of seroconversion for syphilis following a needlestick injury: why not take a prophylaxis?

34. Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.

35. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

36. [Experience at a branch center of the National HIV Protease Inhibitor Registry].

38. [Saquinavir + Zidovudine + Lamivudine in HIV positive naive or not naive patients]

39. [Acute and chronic viral hepatitis in HIV positive patients].

40. [Viral hepatitis in Naples. Etio-epidemiologic aspects and problems deducted from a prospective study].

41. Investigation of intestine function during acute viral hepatitis using combined sugar oral loads.

42. Role of delta infection in the progression to chronicity of acute HBsAg positive hepatitis.

43. [Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies].

44. Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study.

45. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis.

46. Mild pancreatic damage in acute viral hepatitis.

48. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe.

49. [Anti-hepatitis B vaccination in Campania. Final observations of a 3-year vaccination campaign, with special reference to infants born to HBsAg-positive mothers].

Catalog

Books, media, physical & digital resources